Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-12 Sale | 2025-12-16 5:00 pm | CATALYST PHARMACEUTICALS INC. | CPRX | Harper Molly Director | 26,746 | $23.25 | $621,920 | 130,857 (Direct) | View |
| 2025-11-26 Sale | 2025-11-28 5:00 pm | CATALYST PHARMACEUTICALS INC. | CPRX | Del Carmen Jeffrey Chief Commercial Officer | 10,983 | $23.33 | $256,244 | 1,057,514 (Direct) | View |
| 2025-11-12 Sale | 2025-11-14 5:00 pm | CATALYST PHARMACEUTICALS INC. | CPRX | Elsbernd Brian Chief Compliance/Legal Officer | 40,000 | $22.7 | $908,000 | 231,039 (Direct) | View |
| 2025-09-08 Sale | 2025-09-10 5:00 pm | CATALYST PHARMACEUTICALS INC. | CPRX | Elsbernd Brian Chief Compliance/Legal Officer | 30,000 | $20.3 | $609,000 | 1,117,648 (Direct) | View |
| 2025-09-03 Sale | 2025-09-05 5:00 pm | CATALYST PHARMACEUTICALS INC. | CPRX | Elsbernd Brian Chief Compliance/Legal Officer | 50,000 | $19.74 | $987,200 | 2,136,732 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-05 Exercise | 2026-01-06 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Kalb Michael Wayne Executive Vice President & CFO | 7,139 | $0 | 646,568 (Direct) | View |
| 2026-01-05 Tax Withholding | 2026-01-06 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Kalb Michael Wayne Executive Vice President & CFO | 2,080 | $0 | 646,568 (Direct) | View |
| 2026-01-05 Exercise | 2026-01-06 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Daly Richard J President and CEO | 42,105 | $0 | 2,889,805 (Direct) | View |
| 2026-01-05 Tax Withholding | 2026-01-06 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Daly Richard J President and CEO | 10,577 | $0 | 2,889,805 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-30 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | DENKHAUS DONALD A Director | 1,334 | $0 | 676,936 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-30 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Elsbernd Brian Chief Compliance/Legal Officer | 6,667 | $0 | 1,198,643 (Direct) | View |
| 2025-12-29 Tax Withholding | 2025-12-30 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Elsbernd Brian Chief Compliance/Legal Officer | 2,623 | $0 | 1,198,643 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-30 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Tierney David S Director | 1,334 | $0 | 561,477 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-30 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 6,667 | $0 | 853,241 (Direct) | View |
| 2025-12-29 Tax Withholding | 2025-12-30 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 2,369 | $0 | 853,241 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-30 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Miller Steve Chief Op. & Scientific Officer | 14,000 | $0 | 2,565,452 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-30 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Harper Molly Director | 1,334 | $0 | 130,857 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-30 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | MCENANY PATRICK J Chairman of Board of Directors | 26,334 | $0 | 6,023,507 (Direct) | View |
| 2025-12-29 Tax Withholding | 2025-12-30 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | MCENANY PATRICK J Chairman of Board of Directors | 6,786 | $0 | 6,023,507 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-30 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Daly Richard J President and CEO | 1,334 | $0 | 2,900,382 (Direct) | View |
| 2025-12-29 Tax Withholding | 2025-12-30 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Daly Richard J President and CEO | 524 | $0 | 2,900,382 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-30 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Del Carmen Jeffrey Chief Commercial Officer | 8,667 | $0 | 1,051,183 (Direct) | View |
| 2025-12-29 Tax Withholding | 2025-12-30 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Del Carmen Jeffrey Chief Commercial Officer | 3,839 | $0 | 1,051,183 (Direct) | View |
| 2025-12-12 Exercise | 2025-12-16 5:00 pm | N/A 2028-06-29 | CATALYST PHARMACEUTICALS INC. | CPRX | Harper Molly Director | 20,000 | $0 | 130,857 (Direct) | View |
| 2025-12-12 Exercise | 2025-12-16 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Harper Molly Director | 20,000 | $5.78 | 130,857 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-10 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Elsbernd Brian Chief Compliance/Legal Officer | 7,067 | $0 | 1,201,266 (Direct) | View |
| 2025-12-08 Tax Withholding | 2025-12-10 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Elsbernd Brian Chief Compliance/Legal Officer | 2,780 | $0 | 1,201,266 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-10 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Miller Steve Chief Op. & Scientific Officer | 11,873 | $0 | 2,565,452 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-10 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Tierney David S Director | 1,413 | $0 | 561,477 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-10 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Thompson Tamar Director | 1,413 | $0 | 123,436 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-10 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Del Carmen Jeffrey Chief Commercial Officer | 8,039 | $0 | 1,055,022 (Direct) | View |
| 2025-12-08 Tax Withholding | 2025-12-10 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Del Carmen Jeffrey Chief Commercial Officer | 2,492 | $0 | 1,055,022 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-10 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | MCENANY PATRICK J Chairman of Board of Directors | 3,534 | $0 | 6,030,293 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-10 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Harper Molly Director | 1,413 | $0 | 157,603 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-10 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 6,855 | $0 | 855,610 (Direct) | View |
| 2025-12-08 Tax Withholding | 2025-12-10 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 1,669 | $0 | 855,610 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-10 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | DENKHAUS DONALD A Director | 1,413 | $0 | 676,936 (Direct) | View |
| 2025-12-01 Gift | 2025-12-03 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | MCENANY PATRICK J Chairman of Board of Directors | 45,000 | $0 | 4,148,477 (Direct) | View |
| 2025-11-26 Exercise | 2025-11-28 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Del Carmen Jeffrey Chief Commercial Officer | 10,983 | $4.21 | 1,057,514 (Direct) | View |
| 2025-11-26 Exercise | 2025-11-28 5:00 pm | N/A 2027-01-06 | CATALYST PHARMACEUTICALS INC. | CPRX | Del Carmen Jeffrey Chief Commercial Officer | 10,983 | $0 | 1,057,514 (Direct) | View |
| 2025-11-20 Option Award | 2025-11-24 8:08 pm | N/A 2032-11-20 | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 139,130 | $0 | 2,460,146 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 5,603 | $0 | 2,460,146 (Direct) | View |
| 2025-11-21 Tax Withholding | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 1,364 | $0 | 2,460,146 (Direct) | View |
| 2025-11-20 Option Award | 2025-11-24 8:08 pm | N/A 2032-11-20 | CATALYST PHARMACEUTICALS INC. | CPRX | Miller Steve Chief Op. & Scientific Officer | 206,280 | $0 | 5,512,670 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Miller Steve Chief Op. & Scientific Officer | 8,267 | $0 | 5,512,670 (Direct) | View |
| 2025-11-20 Option Award | 2025-11-24 8:08 pm | N/A 2032-11-20 | CATALYST PHARMACEUTICALS INC. | CPRX | Russo Gregg Chief HR Officer | 26,728 | $0 | 138,749 (Direct) | View |
| 2025-11-20 Option Award | 2025-11-24 8:08 pm | N/A 2032-11-20 | CATALYST PHARMACEUTICALS INC. | CPRX | Thompson Tamar Director | 23,583 | $0 | 362,014 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Thompson Tamar Director | 947 | $0 | 362,014 (Direct) | View |
| 2025-11-20 Option Award | 2025-11-24 8:08 pm | N/A 2032-11-20 | CATALYST PHARMACEUTICALS INC. | CPRX | Kalb Michael Wayne Executive Vice President & CFO | 171,237 | $0 | 1,902,819 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Kalb Michael Wayne Executive Vice President & CFO | 6,894 | $0 | 1,902,819 (Direct) | View |
| 2025-11-21 Tax Withholding | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Kalb Michael Wayne Executive Vice President & CFO | 2,485 | $0 | 1,902,819 (Direct) | View |
| 2025-11-20 Option Award | 2025-11-24 8:08 pm | N/A 2032-11-20 | CATALYST PHARMACEUTICALS INC. | CPRX | Tierney David S Director | 23,583 | $0 | 919,723 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Tierney David S Director | 947 | $0 | 919,723 (Direct) | View |
| 2025-11-20 Option Award | 2025-11-24 8:08 pm | N/A 2032-11-20 | CATALYST PHARMACEUTICALS INC. | CPRX | MCENANY PATRICK J Chairman of Board of Directors | 45,461 | $0 | 9,921,935 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | MCENANY PATRICK J Chairman of Board of Directors | 1,775 | $0 | 9,921,935 (Direct) | View |
| 2025-11-20 Option Award | 2025-11-24 8:08 pm | N/A 2032-11-20 | CATALYST PHARMACEUTICALS INC. | CPRX | Harper Molly Director | 23,583 | $0 | 453,849 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Harper Molly Director | 947 | $0 | 453,849 (Direct) | View |
| 2025-11-20 Option Award | 2025-11-24 8:08 pm | N/A 2032-11-20 | CATALYST PHARMACEUTICALS INC. | CPRX | Daly Richard J President and CEO | 497,231 | $0 | 8,129,585 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Daly Richard J President and CEO | 20,006 | $0 | 8,129,585 (Direct) | View |
| 2025-11-21 Tax Withholding | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Daly Richard J President and CEO | 7,872 | $0 | 8,129,585 (Direct) | View |
| 2025-11-20 Option Award | 2025-11-24 8:08 pm | N/A 2032-11-20 | CATALYST PHARMACEUTICALS INC. | CPRX | DENKHAUS DONALD A Director | 23,583 | $0 | 1,035,182 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | DENKHAUS DONALD A Director | 947 | $0 | 1,035,182 (Direct) | View |
| 2025-11-20 Option Award | 2025-11-24 8:08 pm | N/A 2032-11-20 | CATALYST PHARMACEUTICALS INC. | CPRX | Elsbernd Brian Chief Compliance/Legal Officer | 128,428 | $0 | 3,124,244 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Elsbernd Brian Chief Compliance/Legal Officer | 5,161 | $0 | 3,124,244 (Direct) | View |
| 2025-11-21 Tax Withholding | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Elsbernd Brian Chief Compliance/Legal Officer | 2,030 | $0 | 3,124,244 (Direct) | View |
| 2025-11-20 Option Award | 2025-11-24 8:08 pm | N/A 2032-11-20 | CATALYST PHARMACEUTICALS INC. | CPRX | Del Carmen Jeffrey Chief Commercial Officer | 139,130 | $0 | 3,176,516 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Del Carmen Jeffrey Chief Commercial Officer | 5,603 | $0 | 3,176,516 (Direct) | View |
| 2025-11-21 Tax Withholding | 2025-11-24 8:08 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Del Carmen Jeffrey Chief Commercial Officer | 1,641 | $0 | 3,176,516 (Direct) | View |
| 2025-11-20 Option Award | 2025-11-24 8:08 pm | N/A 2032-11-20 | CATALYST PHARMACEUTICALS INC. | CPRX | Curran Daniel J. Director | 23,583 | $0 | 121,698 (Direct) | View |
| 2025-11-20 Option Award | 2025-11-24 8:08 pm | N/A 2032-11-20 | CATALYST PHARMACEUTICALS INC. | CPRX | Andrews William T. Chief Medical Officer | 128,428 | $0 | 506,496 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-10 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Elsbernd Brian Chief Compliance/Legal Officer | 112,475 | $2.24 | 1,117,648 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-10 5:00 pm | N/A 2025-12-19 | CATALYST PHARMACEUTICALS INC. | CPRX | Elsbernd Brian Chief Compliance/Legal Officer | 112,475 | $0 | 1,117,648 (Direct) | View |
| 2025-09-03 Exercise | 2025-09-05 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Elsbernd Brian Chief Compliance/Legal Officer | 50,000 | $2.24 | 2,136,732 (Direct) | View |
| 2025-09-03 Exercise | 2025-09-05 5:00 pm | N/A 2025-12-19 | CATALYST PHARMACEUTICALS INC. | CPRX | Elsbernd Brian Chief Compliance/Legal Officer | 50,000 | $0 | 2,136,732 (Direct) | View |